Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers-Reference-Cited by-同舟云学术

Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers

Published:2017-09 Issue:Supplement 2 Volume:58 Page:17S-26S
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kopka Klaus,Benešová Martina,Bařinka Cyril,Haberkorn Uwe,Babich John

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference97 articles.

1. Prostate-specific membrane antigen as a target for cancer imaging and therapy;Kiess;Q J Nucl Med Mol Imaging.,2015

2. Radiolabeled enzyme inhibitors and binding agents targeting PSMA: effective theranostic tools for imaging and therapy of prostate cancer;Pillai;Nucl Med Biol.,2016

3. New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy

4. Current status of prostate-specific membrane antigen targeting in nuclear medicine: clinical translation of chelator containing prostate-specific membrane antigen ligands into diagnostics and therapy for prostate cancer;Kratochwil;Semin Nucl Med.,2016

5. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Membrane Antigen Biology and Pathophysiology in Prostate Carcinoma, an Update: Potential Implications for Targeted Imaging and Therapy;International Journal of Molecular Sciences;2024-09-09

2. Internal dosimetry assessment of beta, beta/auger, and alpha decaying radionuclides in targeted radionuclide therapy for prostate cancer: a simulation study;Physica Scripta;2024-07-30

3. Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen;2024-07-08

4. Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-29

5. Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m;International Journal of Molecular Sciences;2024-03-23